-
New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis -
Scipher Medicine Announces Publication of Clinical Study Validating PrismRA, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis -
Pandemic versus pandemonium: fighting on two fronts -
COVID-19 might be bitter medicine for what ails AI investing -
Coronavirus: AI steps up in battle against Covid-19 -
Scipher Medicine has developed a blood test expected to save payers billions each year -
Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling -
Scipher: Decoding Drug Response From Protein Interactions -
Getting Personal With Precision Medicine -
Bringing Precision Medicine to Autoimmune Diseases -
How Precision Medicine Can Change the Drug Pricing Conversation -
How A Blood Test Can Disrupt A $20B Market -
Smart Medicine: AI plays an increasingly bigger role in health care -
Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug -
‘Response rate to top selling drugs is 10%’, says Scipher CEO